Percutaneous Treatment Approaches in Atrial Fibrillation: Current Landscape and Future Perspectives

Panagiotis Theofilis1, Evangelos Oikonomou2, Alexios S Antonopoulos1

  • 1First Department of Cardiology, "Hippokration" General Hospital, University of Athens Medical School, 11527 Athens, Greece.

Biomedicines
|September 23, 2022
PubMed

Insights

Atrial fibrillation (AF) management now includes catheter ablation for improved outcomes and left atrial appendage occlusion for stroke prevention, offering new options beyond traditional treatments.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Interventional Cardiology

Background:

  • Atrial fibrillation (AF) is a prevalent arrhythmia causing significant morbidity and mortality.
  • Pharmacologic therapy is standard for rate/rhythm control and thromboembolism prevention.
  • Increasing prevalence necessitates advanced therapeutic strategies.

Purpose of the Study:

  • To review current and emerging interventional strategies for atrial fibrillation management.
  • To evaluate the efficacy of catheter ablation and left atrial appendage occlusion.

Main Methods:

  • Review of current literature on catheter ablation techniques for AF.
  • Analysis of data on percutaneous left atrial appendage occlusion devices.
  • Assessment of outcomes in persistent AF, heart failure, and stroke risk reduction.

Main Results:

  • Catheter ablation demonstrates efficacy in achieving long arrhythmia-free intervals and reducing AF burden.
  • Left atrial appendage occlusion effectively reduces thromboembolic risk, particularly in high-risk patients.
  • Catheter ablation shows promise as a first-line option for persistent AF and heart failure.

Conclusions:

  • Percutaneous interventions, including catheter ablation and LAA occlusion, offer valuable alternatives to pharmacologic therapy.
  • These approaches significantly improve patient outcomes and reduce complications associated with AF.
  • Interventional strategies are crucial for managing AF, especially in specific patient populations.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
18
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
23
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
35
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
104
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
144
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
238